Frontlight ResearchEarly access
Childhood cancers trials in United States
933 trials · From ClinicalTrials.gov, checked 18 November 2026. Ask the study team whether a trial fits you.
- No phaseTaking peopleDevelopment of Patient-Reported Outcome Measures Assessing Tumor Visibility and Appearance Concerns in Neurofibromatosis Type 1: A Qualitative Study
- Where
- Bethesda
- Age
- 5 years to 120 years
- People
- 110
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT06880991 - No phaseTaking peopleStudy of Individuals and Families With Aberrations in DDX41 or Similar Cancer Predisposition Variants
- Where
- Bethesda
- Age
- 1 month to 120 years
- People
- 510
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT07019155 - Phase 1Taking peopleRecombinant Erwinia Asparaginase and Venetoclax in Combination With Blinatumomab for the Treatment of Relapsed or Refractory CD19 Positive B-cell Acute Lymphoblastic Leukemia
- Where
- Duarte
- Age
- 12 years to 55 years
- People
- 26
- Run by
- City of Hope Medical Center
See details and how to joinNCT07133997 - Phase 1Not yet taking people in United StatesAxatilimab + CAR-T for High-Risk Lymphoma
- Where
- Atlanta
- Age
- 8 years and over
- People
- 29
- Run by
- Northside Hospital, Inc.
See details and how to joinNCT07638982 - Phase 2Taking peopleFluorescence-Guided Surgical Resection for Reducing Unexpected Positive Margins in Patients With Sarcoma, SarcoSIGHT Trial
- Where
- Duarte
- People
- 22
- Run by
- City of Hope Medical Center
See details and how to joinNCT07650656 - No phaseTaking peopleEvaluation of Cell Changes in Blood and Tissue in Cancers of the Lung, Esophagus and Lung Lining
- Where
- Bethesda
- Age
- 2 years to 120 years
- People
- 1,559
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT00242723 - Phase 1Taking peopleCAR T Cells After Lymphodepletion for the Treatment of IL13Rα2 Positive Recurrent or Refractory Brain Tumors in Children
- Where
- Ann Arbor, Duarte, Los Angeles
- Age
- 4 years to 25 years
- People
- 18
- Run by
- City of Hope Medical Center
See details and how to joinNCT04510051 - Phase 2Taking peopleUlixertinib in People With Histiocytic Neoplasms
- Where
- Basking Ridge, Commack, Harrison, Middletown, Montvale, New York, Rochester, Uniondale
- Age
- 12 years and over
- People
- 38
- Run by
- Memorial Sloan Kettering Cancer Center
See details and how to joinNCT06411821 - No phaseTaking peopleCIPN Decision Aid for the Improvement of Chemotherapy Decision Making in Patients With Breast Cancer
- Where
- Ann Arbor
- People
- 20
- Run by
- University of Michigan Rogel Cancer Center
See details and how to joinNCT06915168 - No phaseNot yet taking people in United StatesMusic Therapy for Oral Mucositis Pain in Pediatric Patients
- Where
- San Francisco
- Age
- 6 years to 64 years
- People
- 50
- Run by
- University of California, San Francisco
See details and how to joinNCT07653360 - Phase 1Taking peopleNiclosamide in Pediatric Patients With Relapsed and Refractory AML
- Where
- Palo Alto
- Age
- 2 years to 30 years
- People
- 16
- Run by
- Stanford University
See details and how to joinNCT05188170 - Phase 2Taking peopleA Study Using Nivolumab, in Combination With Chemotherapy Drugs to Treat Nasopharyngeal Carcinoma (NPC)
- Where
- Albany, Allentown, Atlanta, Aurora, Austin, Baltimore, Birmingham, Boston, Charlotte, Charlottesville, Chicago, Cincinnati, Cleveland, Columbia, Columbus, Dallas, Dayton, Downey, Durham, Fargo, Fort Worth, Gainesville, Grand Rapids, Greenville, Hackensack, Hartford, Hershey, Houston, Indianapolis, Jackson, Jacksonville, Kansas City, Lexington, Little Rock, Loma Linda, Los Angeles, Madera, Memphis, Miami, Milwaukee, Nashville, Neptune City, Newark, New Brunswick, New Orleans, Norfolk, Oakland, Oklahoma City, Omaha, Orlando, Pensacola, Philadelphia, Phoenix, Pittsburgh, Richmond, Rochester, San Antonio, San Diego, San Francisco, Scarborough, Seattle, Sioux Falls, St Louis, Tacoma, Tampa, The Bronx, Washington D.C., Wilmington, Winston-Salem
- Age
- Up to 21 years
- People
- 50 worldwide
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT06064097 - Phase 2Taking peopleRuxolitinib With Tacrolimus and Methotrexate for the Prevention of Graft Versus Host Disease in Pediatric and Young Adult Patients Undergoing Allogeneic Hematopoietic Cell Transplant for Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Myelodysplastic Syndrome
- Where
- Duarte
- Age
- 2 years to 22 years
- People
- 40
- Run by
- City of Hope Medical Center
See details and how to joinNCT06128070 - Phase 2Taking peopleAntiangiogenic Therapy for Children With Recurrent Medulloblastoma, Ependymoma, ATRT and Rare CNS Tumors
- Where
- Austin, Boston, Chicago, Grand Rapids
- Age
- Up to 19 years
- People
- 232 worldwide
- Run by
- Medical University of Vienna
See details and how to joinNCT01356290 · EU 2024-515626-92-00 - Phase 1/2Taking peopleAZD0486 as Monotherapy in B-cell Acute Lymphoblastic Leukaemia
- Where
- Atlanta, Birmingham, Chicago, Duarte, Houston, Los Angeles, Milwaukee, New York, Palo Alto, Richmond, Seattle, Tampa
- Age
- 12 years and over
- People
- 255 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06137118 · EU 2023-505840-20-00 - Phase 1/2Taking peopleAZD3470 as Monotherapy or in Combination With Anticancer Agent(s) in Participants With Haematologic Malignancies.
- Where
- Atlanta, Boston, Duarte, Houston, Miami, New York, Philadelphia
- Age
- 12 years and over
- People
- 161 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06137144 · EU 2023-506747-42-00 - Phase 1Taking peopleImmunotherapy for Malignant Pediatric Brain Tumors Employing Adoptive Cellular Therapy (IMPACT)
- Where
- Washington D.C.
- Age
- 1 year to 30 years
- People
- 12
- Run by
- Children's National Research Institute
See details and how to joinNCT06193759 - No phaseTaking peopleUltra-Rapid Profiling and Drug Screening for Treatment Selection in Patients With Relapsed or Recurrent Rare Brain Tumors
- Where
- Washington D.C.
- Age
- Up to 45 years
- People
- 20
- Run by
- Adriana Fonseca
See details and how to joinNCT07851636 - No phaseTaking peopleLongitudinal Studies of Patient With FPDMM
- Where
- Bethesda
- Age
- 1 day to 100 years
- People
- 1,000
- Run by
- National Human Genome Research Institute (NHGRI)
See details and how to joinNCT03854318 - Phase 1/2Taking peopleA Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation
- Where
- Atlanta, Aurora, Boston, Chicago, Cincinnati, Columbus, Duarte, Durham, Hackensack, Houston, Iowa City, Los Angeles, New York, Palo Alto, Philadelphia, Portland, Salt Lake City, Sarasota, St Louis, Tampa
- Age
- 30 days and over
- People
- 447 worldwide
- Run by
- Syndax Pharmaceuticals
See details and how to joinNCT04065399 · EU 2024-513759-34-00 - Phase 2Taking peopleTargeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
- Where
- Amarillo, Ames, Anaconda, Anaheim, Anderson, Ankeny, Ann Arbor, Ashland, Athens, Auburn, Aurora, Baldwin Park, Baltimore, Basking Ridge, Bellflower, Bemidji, Berkeley, Beverly Hills, Billings, Bismarck, Bloomington, Boise, Boone, Bozeman, Brewer, Brighton, Burlington, Caldwell, Canton, Cape Girardeau, Carthage, Cedar Rapids, Centerville, Chambersburg, Charleston, Chelsea, Chicago, City of Saint Peters, Clive, Coeur d'Alene, Collierville, Colorado Springs, Columbus, Commack, Concord, Cooperstown, Creve Coeur, Crown Point, Danville, Daphne, Dayton, Decatur, Deer River, DeKalb, Derby, Des Moines, Dickson City, Dixon, Dover, Duluth, Dyer, Eau Claire, Edmonds, Effingham, Ephrata, Eureka, Fairfield, Fairhope, Fairway, Fargo, Flint, Fontana, Fort Collins, Fort Dodge, Franklin, Fremont, Gainesville, Gaithersburg, Galesburg, Geneva, Gettysburg, Glastonbury, Glenview, Grayslake, Great Falls, Greeley, Greenville, Greenwich, Grenada, Guilford, Harbor City, Harrison, Hartford, Hays, Hibbing, Hines, Hobart, Huntington, Indianapolis, Irvine, Issaquah, Jacksonville, Jefferson, Jonesboro, Kalispell, Kansas City, Kewanee, La Crosse, La Jolla, Lake Forest, Lansing, Largo, Las Vegas, Lawrence, Lawton, Lebanon, Lee's Summit, Lewisburg, Lexington, Little Rock, Livonia, Los Angeles, Loveland, Lutherville, Macomb, Manchester, Marshalltown, Marshfield, Mattoon, Maywood, McLean, Memphis, Middletown, Milford, Minocqua, Missoula, Mobile, Modesto, Monroeville, Montvale, Moorestown, Morgantown, Munster, Nampa, New Albany, Newberg, New Haven, New York, North Haven, North Kansas City, Oak Brook, O'Fallon, Oklahoma City, Olathe, Ontario, Oregon City, Orland Park, Ottawa, Overland Park, Oxford, Palo Alto, Panorama City, Pekin, Peoria, Peru, Pinehurst, Pittsburgh, Pontiac, Portland, Post Falls, Princeton, Rancho Mirage, Rice Lake, Riverside, Rochester, Roseville, Sacramento, Saginaw, Salina, Salt Lake City, San Diego, Sandpoint, Sandstone, San Francisco, San Marcos, San Mateo, Santa Cruz, Santa Rosa, Saraland, Scranton, Seattle, Shiloh, Sioux Falls, Southhaven, Springfield, Stamford, Stevens Point, St Louis, Sunnyvale, Sylvania, Tampa, Tarzana, Tawas City, Topeka, Torrance, Torrington, Troy, Trumbull, Uniondale, Urbana, Vallejo, Valparaiso, Virginia, Voorhees Township, Warrenville, Washington, Washington D.C., Waterbury, Waterford, Waukee, West Branch, Weston, Westwood, Wilkes-Barre, Woodbridge, Woodland Hills, Worcester, York, Ypsilanti
- Age
- 18 Minutes and over
- People
- 56
- Run by
- SWOG Cancer Research Network
See details and how to joinNCT06031688 - Phase 1Taking peoplePhase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors
- Where
- Atlanta, Charlottesville, Chicago, Columbus, Detroit, Duarte, Hackensack, Indianapolis, Minneapolis, Nashville, New York, Oklahoma City, Palo Alto, Pittsburgh, San Francisco, Tampa, The Bronx
- Age
- 15 years and over
- People
- 282 worldwide
- Run by
- Xencor, Inc.
See details and how to joinNCT06276491 - Phase 1Taking peopleZiftomenib in Combination With Chemotherapy for Children With Relapsed/Refractory Acute Leukemia
- Where
- Atlanta, Aurora, Boston, Chicago, Cincinnati, Houston, Los Angeles, Memphis, New York, Philadelphia, Seattle
- Age
- 0 years to 21 years
- People
- 20 worldwide
- Run by
- PedAL BCU, LLC
See details and how to joinNCT06376162 · EU 2023-505262-28-00 - Phase 1Taking peopleEngineered HSV-1 M032 for the Treatment of Children and Adults With Newly Diagnosed Diffuse Midline Glioma After Standard of Care Radiation
- Where
- Houston
- Age
- 36 months and over
- People
- 20
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT07076498 - Phase 1Taking peopleGPC2-CAR T Cell Therapy for Relapsed or Refractory Medulloblastoma in Children and Young Adults
- Where
- Palo Alto
- Age
- 1 year to 30 years
- People
- 18
- Run by
- Stanford University
See details and how to joinNCT07087002